By Karen Roman Sequana Medical NV (BRU: SEQUA.BR) said it successfully implanted the alfapump device...

By Daniella Parra March Bio is developing MB-105, a first-in-class autologous CD5-targeted CAR-T cell therapy for...

Exec Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Chris...

IPO Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Christer...

By Daniella Parra ReAlta Life Sciences’ Pegtarazimod demonstrated significant clinical improvement and reduction in inflammatory...

By Karen Roman March Biosciences said it appointed Gurpreet Ratra, Ph.D., as Chief Business Officer. Dr....

By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) said it is presenting new research at...

By Karen Roman ReAlta Life Sciences, Inc. announced the designation of Howard Berman, Ph.D., as Executive...

By Daniella Parra Sequana Medical said the first implantation of the alfapump in the U.S....

By Karen Roman Imviva Biotech said it will present its progress in allogenic cell therapy...